PROVIDER PROFILE · NPI 1700199213
Frank Suppa
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
805
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
6
Brand share
82.9%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam542 claims
Emtricitabine/Tenofovir (Tdf)114 claims
Ondansetron Hcl96 claims
Fluconazole23 claims
Doxycycline Hyclate19 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Frank Suppa's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 83 | 344 |
| EPISCOPAL HEALTH SERVICES INC | 15 | 39 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE